More news
Lanxess projects the highest full year results in company history, following a very strong Q1, 2017 and the successful closing of the acquisition of USA-based company Chemtura.
Global sales increased by 25% to €2.4bn in Q1, 2017, up from €1.9bn yr-on-yr. EBITDA pre exceptionals also improved by 25% to €328M, compared with €262M yr-on-yr. The very positive Q1 development was primarily driven by a significant increase in volumes across all segments. The EBITDA margin pre exceptionals came in at 13.7%, slightly above the prior-year figure of 13.6%. Net income rose significantly by 47% to €78M, against €53M yr-on-yr.
For FY 2017, it expects EBITDA pre exceptionals of between €1.225bn and €1.3bn. Lanxess achieved its highest operating result to date in 2012, when it posted a figure of around €1.2bn.
